Squalamine Lactate Eye Drops in Combination With Ranibizumab in Patients With Diabetic Macular Edema (DME)

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 28, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Diabetic Retinopathy
Interventions
DRUG

Squalamine Lactate Ophthalmic Solution 0.2%

Squalamine Lactate Ophthalmic Solution 0.2% eye drop to be administered to study eye either BID or QID for 52 weeks

Trial Locations (1)

08901

NJ Retina, New Brunswick

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Ohr Pharmaceutical Inc.

INDUSTRY

lead

Starr Muscle

OTHER